1.Effect of beta-lactam antibiotics in drug-induced hemolysis.
Hui LI ; Li YANG ; Xi-Llin OUYANG ; Jing-Han LIU ; Quan-Li WANG
Journal of Experimental Hematology 2006;14(3):597-600
The study was purposed to evaluate synergistic effect of beta-lactam antibiotics in drug-induced hemolysis. The general information, including primary diseases, therapeutic drugs, infection pathogens in 6 patients with pulmonary infection and unknown reason anemia were integrated and analyzed. The leukocyte and reticulocyte counts, total bilirubin (TB), direct bilirubin (DB), fasting blood glucose (Glu in peripheral blood) were all determined by conventional method. At the same time, the erythrocyte direct antiglobulin test (DAT), complement fixation test (CFT), cell culture and smear examination were carried out. The antibodies in plasma were also detected by indirect antiglobulin test (IAT). The result showed that levels of WBC, TB, DB, Glu and reticulocyte in six patients treated with beta-lactam antibiotics were raised remarkably. DAT was strongly positive, but no RBC antibodies were detected in the plasma by IAT. The binding of red cells by monocytes or lymphocytes was great, and the hemolysis of red cells by alexin not appeared. After stopping above-mentioned beta-lactam antibiotic administration, patient's WBC, TB, DB, and Glu levels returned to normal values. Furthermore, DAT test result turned to negative. It is concluded that beta-lactam antibiotics lead to drug-induced hemolysis by non-specific adsorption of some proteins onto RBC surface, and their proteins may be considered as direct cause for this hemolysis.
Aged
;
Anemia, Hemolytic
;
chemically induced
;
etiology
;
Anti-Bacterial Agents
;
adverse effects
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pneumonia, Bacterial
;
complications
;
drug therapy
;
beta-Lactams
;
adverse effects
2.The wheezing associated with Mycoplasma pneumoniae infection in children.
Chinese Journal of Pediatrics 2012;50(10):756-759
Anti-Bacterial Agents
;
therapeutic use
;
Anti-Inflammatory Agents
;
therapeutic use
;
Asthma
;
drug therapy
;
etiology
;
Child
;
Child, Preschool
;
Humans
;
Macrolides
;
therapeutic use
;
Mycoplasma Infections
;
complications
;
drug therapy
;
Mycoplasma pneumoniae
;
isolation & purification
;
Pneumonia, Mycoplasma
;
complications
;
drug therapy
;
Respiratory Sounds
;
drug effects
;
etiology
3.Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment.
Seo Yun KIM ; Jae Joon YIM ; Jong Sun PARK ; Sung Soo PARK ; Eun Young HEO ; Chang Hoon LEE ; Hee Soon CHUNG ; Deog Kyeom KIM
Journal of Korean Medical Science 2013;28(3):378-382
Although gemifloxacin has low in vitro activity against Mycobacterium tuberculosis, the effect of gemifloxacin on the delay of tuberculosis (TB) treatment has not been validated in a clinical setting. The study group included patients with culture-confirmed pulmonary TB who initially received gemifloxacin for suspected community-acquired pneumonia (CAP). Two control groups contained patients treated with other fluoroquinolones or nonfluoroquinolone antibiotics. Sixteen cases were treated with gemifloxacin for suspected CAP before TB diagnosis. Sixteen and 32 patients were treated with other fluoroquinolones and nonfluoroquinolones, respectively. The median period from the initiation of antibiotics to the administration of anti-TB medication was nine days in the gemifloxacin group, which was significantly different from the other fluoroquinolones group (35 days). The median times for the nonfluoroquinolone group and the gemifloxacin group were not significantly different. There were no significant differences between the gemifloxacin and other fluoroquinolone group in terms of symptomatic and radiographic improvements. However, the frequency of radiographic improvement in the other fluoroquinolones group tended to be higher than in the gemifloxacin group. Gemifloxacin might be the preferred fluoroquinolone for treating CAP, to alleviate any concerns about delaying TB treatment.
Adult
;
Aged
;
Anti-Bacterial Agents/*therapeutic use
;
Case-Control Studies
;
Fluoroquinolones/*therapeutic use
;
Humans
;
Middle Aged
;
Naphthyridines/*therapeutic use
;
Pneumonia/complications/diagnosis
;
Tuberculosis/complications/*drug therapy/radiography
4.Diagnosis and treatment of bacterial pneumonia in liver transplantation recipients: report of 33 cases.
Yu-kui MA ; Lü-nan YAN ; Bo LI ; Shi-chun LU ; An-hua HUANG ; Tian-fu WEN ; Yong ZENG ; Nan-sheng CHENG
Chinese Medical Journal 2005;118(22):1879-1885
BACKGROUNDBacterial pneumonia in the recipients of liver transplantation (LTX) is a common postoperative complication influencing the prognosis greatly. In this article, the diagnosis and treatment of bacterial pneumonia in 33 LTX recipients are reported.
METHODSFrom February 1999 to January 2003, a total of 103 patients underwent allogeneic LTX at our center; afterwards, a retrospective analysis was made on their postoperative clinical manifestations, including symptoms (expectoration, panting and fever), sign (rale), results of laboratory examinations (white blood cell count and sputum culture of tracheal secretions or pleural fluid culture), and chest X-ray films. The following data of the pneumonia and non-pneumonia groups were collected, and the rank sum test (SPSS 11.0, Wilcoxon's method) was used to analyze the duration of postoperative respirator utilization and the volume of pleural effusion through pleurocentesis or pleural drainage.
RESULTSIn the 103 patients, 33 experienced 53 episodes of bacterial pneumonia during their hospital stay after transplantation, 14 of them (42.42%) had more than three manifestations of the seven mentioned above. The pathogens causing bacterial pneumonia included Pseudomonas aeruginosa (17.48%), Klebsiella pneumoniae (15.53%), Acinetobacter baumannii (10.68%), and Staphylococcus aureus (7.77%). Amilkacin, tienam, ciprofloxacin, vancomycin, etc. were the antibiotics of choice against those bacteria. Acute rejection occurred during the treatment of bacterial pneumonia in 16 patients, and 5 of them died. Wilcoxon's rank sum test of the data indicated that the pneumonia group had longer duration of postoperative ventilator treatment and larger volume of pleural effusion than the non-pneumonia group (P < 0.05).
CONCLUSIONSThe clinical manifestations of pneumonia after LTX might be atypical, and special attention should be paid to the respiratory symptoms and signs within 2 months after LTX. Whenever the diagnosis of bacterial pneumonia is confirmed, consideration should be given to reasonable use of antibiotics and regulation of immunity in addition to other routine therapies.
Adult ; Aged ; Anti-Bacterial Agents ; therapeutic use ; Female ; Humans ; Liver Transplantation ; adverse effects ; Male ; Middle Aged ; Pneumonia, Bacterial ; diagnosis ; drug therapy ; immunology ; Postoperative Complications ; diagnosis ; drug therapy ; immunology ; Retrospective Studies
5.Mycoplasma pneumoniae pneumonia in hospitalized children diagnosed at acute stage by paired sera.
Chun-Ling LIU ; Gui-Qiang WANG ; Bo ZHANG ; Hua XU ; Liang-Ping HU ; Xiao-Feng HE ; Jun-Hua WANG ; Jun-Hong ZHANG ; Xiao-Yu LIU ; Ming WEI ; Zhen-Ye LIU
Chinese Medical Journal 2010;123(23):3444-3450
BACKGROUNDMycoplasma pneumoniae (M. pneumoniae) is a frequent cause of respiratory tract infections. However, there is deficient knowledge about the clinical manifestations of M. pneumoniae infection. We described the clinical and laboratory findings of M. pneumoniae pneumonia in hospitalized children who were all diagnosed by a ≥ fourfold increase in antibody titer.
METHODSM. pneumoniae antibodies were routinely detected in children admitted with acute respiratory infection during a one-year period. The medical history was re-collected from children whose M. pneumoniae antibody titer increased ≥ fourfold at the bedside by a single person, and their frozen paired serum samples were measured again for the M. pneumoniae antibody titer.
RESULTSOf the 635 children whose sera were detected for the M. pneumoniae antibody, paired sera were obtained from 82 and 29.3% (24/82) showed a ≥ fourfold increase in antibody titer. There were 24 cases, nine boys and 15 girls, aged from two to 14 years, whose second serum samples were taken on day 9 at the earliest after symptom onset; the shortest interval was three days. All children presented with a high fever (≥ 38.5°C) and coughing. Twenty-one had no nasal obstruction or a runny nose, and five had mild headaches which all were associated with the high fever. The disease was comparatively severe if the peak temperature was > 39.5°C. All were diagnosed as having pneumonia through chest X-rays. Four had bilateral or multilobar involvement and their peak temperatures were all ≤ 39.5°C. None of the children had difficulty in breathing and all showed no signs of wheezing.
CONCLUSIONSThe second serum sample could be taken on day 9 at the earliest after symptom onset meant that paired sera could be used for the clinical diagnosis of M. pneumoniae pneumonia in children at the acute stage. M. pneumoniae is a lower respiratory tract pathogen. Extrapulmonary complications were rare and minor in our study. High peak temperature (> 39.5°C) is correlated with the severity of M. pneumoniae pneumonia in children.
Acute Disease ; Adolescent ; Antibodies, Bacterial ; blood ; Child ; Child, Hospitalized ; Child, Preschool ; Female ; Humans ; Male ; Mycoplasma pneumoniae ; immunology ; Pneumonia, Mycoplasma ; complications ; diagnosis ; drug therapy ; Radiography, Thoracic
6.Infection in patients with malignant tumors.
Journal of Central South University(Medical Sciences) 2010;35(11):1183-1188
OBJECTIVE:
To investigate the characters of infection in patients with malignant tumors, especially the distribution, yearly change of pathogens, and pathogen resistance to common antibacterial agents.
METHODS:
We respectively analyzed the characters of infection in 489 patients with malignant tumors.
RESULTS:
The respiratory tract was the most frequent infection site (61.1%). The infection was mainly caused by opportunistic pathogens. The Gram-negative bacterias mainly consisted of Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii (46.3%). The Gram-positive bacteria mainly consisted of Staphylococcus aureus and Staphylococcus epidermidis (29.9%), and the rest 23.8% of the infection was caused by different fungi, mainly consisting of Candida albicans. The ratio of the Gram-negative bacteria resistance to antibiotics such as penicillins, cephalosporins (except ceftazidime), sulfanilamides, tetracyclines and quinolones was higher. The ratio of the Gram-positive bacteria resistance to antibiotics such as penicillins, macrolides and quinolones was higher. The ratio of fungus resistance to antibacterial agents such as fluconazol and itraconazole was higher. The infection caused by fungi obviously increased in the past 5 years.
CONCLUSION
The infection in patients with malignant tumors is mainly caused by opportunistic pathogens, and the pathogen resistance to antibacterial agents is serious. The infection caused by fungi is increasing.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents
;
therapeutic use
;
Communicable Diseases
;
complications
;
drug therapy
;
microbiology
;
Drug Resistance, Microbial
;
Female
;
Humans
;
Lung Neoplasms
;
complications
;
Male
;
Middle Aged
;
Neoplasms
;
complications
;
Pneumonia
;
complications
;
drug therapy
;
microbiology
;
Pseudomonas Infections
;
drug therapy
;
Staphylococcal Infections
;
drug therapy
;
Young Adult
7.An Overlooked Cause of Impaired Consciousness in a Hemodialysis Patient.
Jun Young LEE ; Kyung Pyo KANG ; Won KIM ; Sung Kwang PARK ; Sik LEE
The Korean Journal of Internal Medicine 2012;27(3):367-367
No abstract available.
Aged
;
Anti-Bacterial Agents/*adverse effects
;
Anticonvulsants/therapeutic use
;
Cephalosporins/*adverse effects
;
Consciousness Disorders/diagnosis/drug therapy/*etiology
;
Diabetic Nephropathies/complications/*therapy
;
Electroencephalography
;
Female
;
Humans
;
Pneumonia, Bacterial/complications/*drug therapy
;
*Renal Dialysis
;
Status Epilepticus/diagnosis/drug therapy/*etiology
;
Treatment Outcome
;
Uremia/therapy
8.Clinical analysis of 20 cases with Streptococcus pneumoniae necrotizing pneumonia in China.
Jin-rong LIU ; Bao-ping XU ; Hui-min LI ; Ji-hang SUN ; Bao-lin TIAN ; Shun-ying ZHAO ; Zai-fang JIANG
Chinese Journal of Pediatrics 2012;50(6):431-434
OBJECTIVEStreptococcus pneumoniae necrotizing pneumonia (SPNP) was reported elsewhere but not in China yet. Inappropriate treatment due to poor recognition of this disease could influence its prognosis. This paper presents the clinical characteristics, diagnosis and treatment of SPNP hoping to elevate pediatrician's recognition level for this disease.
METHODClinical manifestations, radiological findings, treatment and prognosis of 20 patients (9 boys, 11 girls) who had been hospitalized with SPNP in Beijing Children's Hospital from 2004-2011 were retrospectively analyzed.
RESULTThe patients included in this study aged from 9 months to 6 years [(27.9 ± 15.8) m] and were healthy before admission. They were febrile for 8 to 50 days [(27.7 ± 13.5) d] and hospital day was 24 - 55 days [(36.5 ± 8.3) d]. The general condition of all subjects was relatively poor and they all had fever and cough. One child had moderate fever and nineteen children had high fever. Dyspnea was found in sixteen children. Fine rales were found on auscultation in 18 children, among whom diffuse wheeze appeared in 4 children, and wheezy phlegm was found in two children. Signs of pleural effusion were discovered in all cases by physical examination and chest X-ray. White blood cell (WBC) count was 16.2 - 60.95×10(9)/L and neutrophil was 70.5% - 80.2% in peripheral blood routine test. Erythrocyte sedimentation rate (ESR) was 44 - 109 mm/h [(69.6 ± 16) mm/h]and C-reactive protein (CRP) was 80 - > 160 mg/L. The pleural effusion biochemistry and routine test revealed a WBC count of 6400×10(6)/L-too much to count, polykaryocyte of 51% - 90%, glucose of 0.02 - 1.8 mmol/L, protein of 32 - 51 g/L and LDH of 5475 IU/L-or higher. Pleural effusion culture in all cases and blood culture in 2 cases was positive for Streptococcus pneumoniae. Chest X-ray or CT revealed high density and well-distributed lobar consolidation in one lung or two lungs initially. Single or multiple low density lesions in the area of lobar consolidation were found a week later, accompanied by multiple cystic shadow or cavity at the same time or afterwards. Bulla of lung appeared later. Pleural effusions were found in all patients. Seven cases complicated with hydropneumothorax, two with otitis media, one with heart failure, one with cardiac insufficiency. Seventeen patients were treated with vancomycin or teicoplanin or linezolid two with amoxicillin and clavulanate potassium. Other two patients had been treated with meropenem and cephalosporin antibiotics respectively before admission, and they had been at recovery stage when they were hospitalized. Thoracic close drainage and thoracoscopy were performed respectively in 18 cases and 3 cases, respectively. After a follow up of more than 6 months, chest CT showed that almost all lesions in lungs recovered during 4-6 months. No one received pneumonectomy.
CONCLUSIONSPNP has special manifestations. The incidence in infants is higher. Patients' general condition is poor and febrile course is relatively long. All patients manifested fever and cough, with a presence of dyspnea in most of them. WBC, neutrophil and CRP elevated apparently. The characteristic of pleural effusion indicates empyema. In early stage, the chest X-ray and CT showed high-density lobar lesions, followed by low-density lesions and cyst gradually. Bulla of lung and/or hydropneumothorax may appear at the late stage. But if diagnosed and treated promptly, the prognosis of SPNP was relatively good.
Anti-Bacterial Agents ; therapeutic use ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Dyspnea ; diagnosis ; drug therapy ; epidemiology ; Female ; Fever ; diagnosis ; drug therapy ; epidemiology ; Humans ; Infant ; Leukocyte Count ; Lung ; diagnostic imaging ; pathology ; Male ; Methylprednisolone ; therapeutic use ; Pleural Effusion ; diagnosis ; drug therapy ; epidemiology ; Pneumonia, Pneumococcal ; complications ; diagnosis ; drug therapy ; Prognosis ; Retrospective Studies ; Streptococcus pneumoniae ; drug effects ; isolation & purification ; pathogenicity ; Tomography, X-Ray Computed ; Treatment Outcome
9.Antibiotic-induced Severe Neutropenia with Multidrug-Dependent Antineutrophil Antibodies Developed in A Child with Streptococcus pneumoniae Infection.
Young Ho LEE ; Ha Baik LEE ; Jung Yun KIM ; Yeon Jung LIM ; Su A SHIN ; Tae Hee HAN
Journal of Korean Medical Science 2009;24(5):975-978
Drug-induced neutropenia (DIN), particularly that in which antibiotic-dependent antineutrophil antibodies have been detected, is a rare disorder. We report the case of a child with pneumococcal pneumonia, who experienced severe neutropenia during various antibiotic treatments. We detected 4 kinds (cefotaxim, augmentin, vancomycin, and tobramycin) of antibiotic-dependent antineutrophil antibodies by using the mixed passive hemagglutination assay (MPHA) technique with this child.
Anti-Bacterial Agents/*therapeutic use
;
Antibodies, Antineutrophil Cytoplasmic/*blood/immunology
;
Autoantibodies/blood/immunology
;
Drug Therapy, Combination
;
Humans
;
Infant
;
Male
;
Neutropenia/chemically induced/*diagnosis
;
Pneumonia, Pneumococcal/complications/*drug therapy
;
Tomography, X-Ray Computed
10.An Adult Case of Fisher Syndrome Subsequent to Mycoplasma pneumoniae Infection.
So Yeon LEE ; Yong Hoon LEE ; Bo Young CHUN ; Shin Yup LEE ; Seung Ick CHA ; Chang Ho KIM ; Jae Yong PARK ; Jaehee LEE
Journal of Korean Medical Science 2013;28(1):152-155
Reported herein is an adult case of Fisher syndrome (FS) that occurred as a complication during the course of community-acquired pneumonia caused by Mycoplasma pneumoniae. A 38-yr-old man who had been treated with antibiotics for serologically proven M. pneumoniae pneumonia presented with a sudden onset of diplopia, ataxic gait, and areflexia. A thorough evaluation including brain imaging, cerebrospinal fluid examination, a nerve conduction study, and detection of serum anti-ganglioside GQ1b antibody titers led to the diagnosis of FS. Antibiotic treatment of the underlying M. pneumoniae pneumonia was maintained without additional immunomodulatory agents. A complete and spontaneous resolution of neurologic abnormalities was observed within 1 month, accompanied by resolution of lung lesions.
Adult
;
Anti-Bacterial Agents/therapeutic use
;
Antibodies/blood
;
Diplopia/etiology
;
Erythrocyte Count
;
Gangliosides/immunology
;
Humans
;
Lung/radiography
;
Male
;
Miller Fisher Syndrome/*diagnosis/etiology
;
Pneumonia, Mycoplasma/complications/*diagnosis/drug therapy
;
Tomography, X-Ray Computed